Complications/adverse effects of maxillomandibular advancement for the treatment of OSA in regard to outcome
This article was presented at the 2005 AAO–HNSF Annual Meeting & OTO EXPO, Los Angeles, CA, September 25-28, 2005.
Received 19 January 2009; received in revised form 26 June 2009; accepted 24 August 2009.
Abstract
Objective
To evaluate adverse effects/postoperative complications and surgical response rate of maxillomandibular advancement for the treatment of severe obstructive sleep apnea syndrome.
Study Design
Case series with chart review.
Setting
Otolaryngology Head and Neck Surgery Department in a teaching hospital.
Subjects and Methods
A total of 59 consecutive severe sleep apnea patients underwent maxillomandibular advancement. Systemic complications were evaluated from medical charts. Functional adverse effects and cosmetic consequences were evaluated by questionnaires. The treatment outcome was assessed by polysomnography.
Results
Fifty patients were evaluated. They had a mean age of 46.4 ± 9.0 years. No serious postoperative complication was observed. The most frequent local complication was mental nerve sensory loss. Most patients reported cosmetic changes. The mean apnea-hypopnea index decreased from 65.5 ± 26.7 per hour to 14.4 ± 14.5 per hour (P < 0.0001). Light-sleep stages were also decreased (P < 0.0001), whereas deep-sleep stages were increased (P < 0.001).
Conclusion
Maxillomandibular advancement can induce local adverse effects and cosmetic changes, but they seem to be considered as secondary to the patients according to the surgical outcome.
aENT Head and Neck Surgery, Foch Hospital, Suresnes, France
bOral and Maxillofacial Surgery, Foch Hospital, Suresnes, France
ABSTRACT